Literature DB >> 10848821

Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation.

J Amiral1, C Pouplard, A M Vissac, J M Walenga, W Jeske, Y Gruel.   

Abstract

Antibodies to heparin platelet factor 4 (H-PF4) complexes were purified from the plasma of three patients with heparin-induced thrombocytopenia (HIT) using affinity chromatography. From each plasma, the largest amount of antibodies was eluted with 2 M NaCl at pH 7.5 (peak 1) and the remainder was obtained using 0.1 M glycine/0. 5 M NaCl at pH 2.5 (peak 2). In an enzyme-linked immunosorbent assay (ELISA), we then showed that each patient had developed antibodies to PF4 displaying different characteristics. In patient 1, peak 1 IgG reacted almost exclusively with H-PF4 complexes, whereas peak 2 IgG had similar reactivity with PF4 whether or not heparin was present. Patient 2 expressed a mixture of IgA, IgM and IgG and both fractions bound to PF4 alone or to H-PF4 complexes. Finally, IgG in patient 3 only bound to H-PF4 and was unreactive with PF4 alone. Using [14C]-serotonin release assays, the antibodies developed in the three patients and exhibiting the strongest ability to activate platelets with heparin were those having the highest affinity to H-PF4. These results strongly support the hypothesis that HIT antibodies to PF4 are heterogeneous regarding their affinity and specificity for target antigens and this may greatly influence their ability to activate platelets and their pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848821     DOI: 10.1046/j.1365-2141.2000.02034.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Improving the specificity of the PF4 ELISA in diagnosing heparin-induced thrombocytopenia.

Authors:  Janice McFarland; Andrew Lochowicz; Richard Aster; Bryan Chappell; Brian Curtis
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

2.  Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.

Authors:  Lubica Rauova; Li Zhai; M Anna Kowalska; Gowthami M Arepally; Douglas B Cines; Mortimer Poncz
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

3.  Lower limb gangrene postcardiac surgery.

Authors:  Hamoun Rozati; Sonya Pratik Shah; Ying Ying Peng
Journal:  BMJ Case Rep       Date:  2013-02-15

4.  Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT.

Authors:  M Anna Kowalska; Sriram Krishnaswamy; Lubica Rauova; Li Zhai; Vincent Hayes; Karine Amirikian; Jeffrey D Esko; Daniel W Bougie; Richard H Aster; Douglas B Cines; Mortimer Poncz
Journal:  Blood       Date:  2011-07-19       Impact factor: 22.113

5.  Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.

Authors:  Elena Ossipova; Cátia Fernandes Cerqueira; Evan Reed; Nastya Kharlamova; Lena Israelsson; Rikard Holmdahl; Kutty Selva Nandakumar; Marianne Engström; Ulrike Harre; Georg Schett; Anca I Catrina; Vivianne Malmström; Yngve Sommarin; Lars Klareskog; Per-Johan Jakobsson; Karin Lundberg
Journal:  Arthritis Res Ther       Date:  2014-08-12       Impact factor: 5.156

Review 6.  The Role of Single-Molecule Force Spectroscopy in Unraveling Typical and Autoimmune Heparin-induced Thrombocytopenia.

Authors:  Van-Chien Bui; Thi-Huong Nguyen
Journal:  Int J Mol Sci       Date:  2018-04-02       Impact factor: 5.923

7.  Myocardial Infarction with Limb Arterial and Venous Thrombosis in a Patient with Enoxaparin-Induced Thrombocytopenia.

Authors:  Navdeep Singh; Sandeep Singh Lubana; Han-Mou Tsai
Journal:  Am J Case Rep       Date:  2020-05-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.